news.cision.com

Proman Stena Bulk Ltd has finalized an agreement to build an additional vessel under its joint venture partnership. The methanol-powered Stena Prosperous will join the Stena ProPatria and the Stena ProMare in the Proman Stena fleet in H2 2022. Each vessel will use 12,500 tonnes per annum of methanol as a marine fuel, significantly reducing emissions in their normal commercial operations compared to conventional marine fuels. These new methanol-ready 49,900 DWT vessels will be state of the art, benefitting from several design and technical improvements to optimise energy

Additional lock-up agreements have been signed by Chairman of the board and management

DanCann Pharma A/S (” DanCann Pharma” or the “Company”) hereby announces that additional board members and management have been allotted units in the IPO. DanCann Pharma’s Chairman of the Board, Magnus Østergaard Dahlmann, Chief Commercial Officer, John Morell Frellsen (who works for the Company as a consultant and is thereby not part of the Company’s registered executive management) and Chief Financial Officer, Mads Møller Kristensen (’the “Subscribers’’) that subscribed for units in the fully subscribed IPO have now been allotted units after the subscription period ended on October 23[rd]

Metso Outotec launches compact large-capacity primary crusher for above and underground applications

Metso Outotec Corporation’s press release on November 10, 2020, at 10:00 a.m. EET Metso Outotec is launching an extension to it’s primary gyratory crusher range: The SUPERIOR™ MKIII 6275UG. The new crusher, which can be used in different types of applications, provides large capacity with significant savings in CAPEX and operating costs. “We are very excited about the SUPERIOR™ MKIII 6275UG. As a direct response to the market demand, we’ve designed a more compact primary gyratory crusher reducing CAPEX that is applicable to both underground and above ground applications for the

Elisa to deliver fully automated network operations to T-Mobile Czech Republic and Slovak Telekom

ELISA CORPORATION INVESTOR NEWS 10 NOVEMBER 2020 AT 10:00 AMElisa Automate’s network automation solution, Virtual NOC (Network Operating Centre), has been selected by Deutsche Telekom Group companies T-Mobile Czech Republic and Slovak Telekom. Elisa Automate is part of Elisa's international digital services business. The automated cloud-based solution benefits from machine learning (ML) and artificial intelligence (AI). It delivers real-time monitoring, zero-touch process automation and predictive capabilities to enhance operations. These features enable optimising network-related costs,

Nordnet exclusive retail selling agent in Nordnet’s contemplated IPO

Tue, Nov 10, 2020 08:51 CET

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE. Press release 10 November 2020On 5 November 2020, Nordnet AB (publ) ("Nordnet") announced its intention to launch an initial public offering of its shares and to list its shares on Nasdaq Stockholm (the "IPO"). Today, we announce that Nordnet, through its

Disclosure of large shareholding in Saga Tankers ASA-EGM

Martin Nes, Chairman of Saga Tankers ASA, has received proxies representing 23 265 588 shares, corresponding to 6.84 % of the company, for the upcomming extraordinary general meeting in Saga Tankers ASA on 10 November 2020. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

The subscription period in Cessatech’s issue of units starts today

Tue, Nov 10, 2020 08:45 CET

Today, 10 November 2020, is the first day of the subscription period in Cessatech A/S ("Cessatech") issue of units. The subscription period lasts until 24 November 2020. A fully subscribed issue of units will initially provide Cessatech with approx. DKK 15.8 million (before issue costs) and an additional approx. DKK 25.2 million (before issue costs) at a later stage if all warrants are exercised. Prior to the issue of units, Cessatech has received subscription commitments from, among others, members of the Board of Directors, executive management and major shareholders. In total, the

Aker Solutions ASA: Merger With Kværner ASA to Be Completed

Tue, Nov 10, 2020 08:40 CET

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. November 10, 2020 - Reference is made to the previous stock exchange announcements made by Aker Solutions ASA (“Aker Solutions”) regarding the contemplated merger with Kværner ASA (“Kvaerner”) as further set out in the merger plan dated July 17,

Asetek Receives Order from Existing Global Data Center OEM

Tue, Nov 10, 2020 08:38 CET

Aalborg, Denmark, 10 November 2020 – Asetek today announced a new order from a current global HPC OEM. The order value is approximately USD 475,000 depending on final order details with delivery in Q1 2021. This is the 11th Data Center order announced this year, representing an aggregated value of USD 6.3 million. About AsetekAsetek, the creator of the all-in-one liquid cooler, is the global leader for liquid cooling solutions for high performance gaming and enthusiast PCs, and environmentally aware data centers. Founded in 2000, Asetek is headquartered in Denmark and has operations

Nomination Committee appointed before the annual general meeting of Bioservo 2021

In line with the decision taken during the Annual General Meeting on May 7, 2020, Bioservo’s Chairman of the Board has contacted the company's largest owners to form a nomination committee. Counted as an owner is also a group of two or more shareholders (shareholder group) if they have notified the Chairman of the Board that they wish to participate in the work of the nomination committee together. The following shareholders and representatives are part of the Nomination Committee, in addition to Anders Lundmark, Chairman of the Board: · Runar Bjørklund, nominated by Tellacq AB,

INTERIM REPORT Period from January 2020 to September 2020

Lune Group OY incl subsidiary is consolidated in the group from 2020-06-03 Peptonic Medical AB (publ) org nr 556776-3064 (www.aktietorget.se ticker: PMED) Group, Lune Group OY incl subsidiary is included from 2020-06-03 2020 THIRD QUARTER (Jul-Sep) · Net sales of products KSEK 9 260 (1 533) · Gross profit KSEK 6 228 (692), Gross margin 67% (45%) · Operating loss KSEK -7 264 (-4 127) · Loss per share SEK -0.04 (-0.04) 2020 FIRST NINE MONTHS (Jan-Sep) · Net sales of products KSEK 13 732 (4 014) · Gross profit KSEK 9 608 (2 262), Gross margin 70% (56%)

ORGANOCLICK AB (PUBL) PUBLISH INTERIM REPORT FOR Q3 2020

"During the third quarter, we had a good development in all our business units. In total, the Group experienced a sales growth of 28 percent totalling sales of MSEK 19.9 (15.6) during the quarter. Gross margin (after variable costs) increased by 5 percentage points to 40.5 (35.6) percent as well, due to changes of the product mix. The result also improved slightly – but, above all, we improved cash flow from operating activities to MSEK 3.4 (1.8) for the quarter and to MSEK 0.2 (-1.3) for the first nine months of the year."Translation from CEO Mårten Hellbergs comments to the Interim Report.

MEDIVIR AB – INTERIM REPORT JANUARY – SEPTEMBER 2020

Continued focus on MIV-818July – SeptemberSignificant events during the quarter · In July, a research collaboration was initiated with the Drug Discovery and Development Platform (DDD) at SciLifeLab on potential inhibitors of SARS CoV-2. Through the collaboration, DDD will get access to Medivir’s unique proprietary protease-targeted compound library. Financial summary for the quarter · Net turnover amounted to SEK 1.1 (1.7) million. · The profit before interest, tax, depreciation and amortization (EBITDA) amounted to SEK 5.2 (-22.0) million. Basic and diluted earnings per

Kværner ASA: Merger with Aker Solutions ASA to be completed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. 10 November 2020 - Reference is made to the previous stock exchange announcements made by Kværner ASA (“Kvaerner”) regarding the contemplated merger with Aker Solutions ASA (“Aker Solutions”) as further set out in the merger plan dated 17 July 2020 (

Extended fiscal year July 2019 - December 2020 Interim report July – September 2020

Registration preparations in Europe, Financing for MOB-015 secured and spin-off of BUPIPERIOD (JUL 2019-SEP 2020) · Net revenue SEK 50.5 million (15.6) * · EBITDA SEK 24.4 million (-3.0) * · Operating profit (EBIT) SEK 21.2 million (-4.2) * · Profit after tax SEK 15.4 million (-4.7) * · Total comprehensive income SEK 15.4 million (499.4) · Diluted earnings per share SEK 0.81 (-0.27) * · Cash and cash equivalents amounted to SEK 30.0 million (919.1) Comparative figures for the period refer to January 2019 - June 2019 (Note: 15 months vs. 6 months due to shortened

Elkem achieves Gold sustainability rating from EcoVadis

Elkem, one of the world's leading suppliers of silicon-based advanced materials, has been awarded a Gold level rating by EcoVadis for the company’s sustainability performance and corporate social responsibility.With a score of 70/100, Elkem is rated among the top 5 percent of the more than 65.000 companies assessed. The company has increased its score from 62/100 in 2019 and is among the top 3 percent of companies in the sector of manufacturers of basic products and other non-ferrous metals. “This strong rating reaffirms Elkem’s position as one of the world’s leading companies in the

City of Espoo, Finland improves the energy efficiency and remote management of its properties – supported by Caverion

Caverion Corporation 10 November 2020 at 9.00 a.m. EETCity of Espoo, Finland improves the energy efficiency and remote management of its properties – supported by Caverion The City of Espoo is improving the energy efficiency of its properties in accordance with its carbon neutrality goal. Espoo has now chosen Caverion as its service provider for the energy and remote management of building automation in its properties. The service contract between Espoo and Caverion will gradually cover about 400 properties of the city and in the future also new and renovated buildings. The

Bio-Works continues investing in the Indian market with BioLinx India as distributor and Dr Ravi Rayanade as Director Regional Sales, India

Bio-Works Technologies (Nasdaq First North) recently signed a distribution agreement with BioLinx India Pvt Ltd, Mumbai, to import, distribute, promote and sell all its products in India to Academia, Hospitals & Clinics and Biotech SMEs. Bio-Works has also engaged Dr Ravi Rayanade as Director Regional Sales. Dr Rayanade is a seasoned bioprocess expert with a wide network in the Indian biotech industry.Bio-Works is further strengthening its presence in the Indian market to take advantage of the many opportunities arising from local companies’ expertise in developing new vaccines and

NENT Group and Starz to launch Starzplay on Viaplay

· Starzplay titles available on Viaplay across Nordic region beginning in December · Full Starzplay service to be offered through Viaplay at a later date · NENT Group and Starz in discussions to extend partnership to additional markets Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, and premium global streaming platform Starz have announced a long-term agreement that makes NENT Group’s Viaplay streaming service the exclusive Nordic launch partner for Starz’s international premium streaming service Starzplay. Beginning in December, a wide

Tezepelumab NAVIGATOR Phase III trial met primary endpoint of a statistically significant and clinically meaningful reduction in exacerbations in a broad population of patients with severe asthma

This announcement contains inside information 10 November 2020 07:00 GMT Tezepelumab NAVIGATOR Phase III trial met primary endpoint of a statistically significant and clinically meaningful reduction in exacerbations in a broad population of patients with severe asthma Trial also met the primary endpoint in patients with low levels of eosinophils AstraZeneca and Amgen today announced positive results from the NAVIGATOR Phase III trial for the potential new medicine tezepelumab in patients with severe, uncontrolled asthma. NAVIGATOR met the primary endpoint

Insourcing of maintenance after successful transformation